Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.550
-0.070 (-1.93%)
At close: Apr 2, 2026, 4:00 PM EDT
3.560
+0.010 (0.28%)
After-hours: Apr 2, 2026, 7:30 PM EDT
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $385.42 million as of April 2, 2026. Its market cap has decreased by -57.28% in one year.
Market Cap
385.42M
Enterprise Value
221.37M
1-Year Change
-57.28%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $385.42M, an increase of 304.43%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 385.40M | 1.45% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 401.63M |
| Sutro Biopharma | 393.97M |
| XOMA Royalty | 392.98M |
| Lineage Cell Therapeutics | 391.07M |
| X4 Pharmaceuticals | 385.50M |
| Century Therapeutics | 382.81M |
| Enanta Pharmaceuticals | 381.31M |
| Autolus Therapeutics | 375.26M |